Ardigen, a Poland-based AI Contract Research Organisation (AI CRO), announced on Tuesday that it has named Livia Legg as its new chief commercial officer.

Legg has experience in global business development, sales and marketing leadership. She most recently served as chief commercial officer at Shanghai ChemPartner and general manager of ChemPartner Corporation US & EU. Legg's career also includes international leadership positions, which include vice president, executive director and head of Global Business Development at QPS, LLC and earlier served in strategic roles at MDS Pharma Services and Merck Pharmaceutical Company.

Janusz Homa, Ardigen CEO, said: "Livia Legg's extensive experience in the industry and her remarkable success in business development and commercial operations make her an invaluable addition to Ardigen's leadership team. Her insights and strategic vision will be over the next few years crucial as we aim for ambitious growth and seek to scale our impact in the biotech and pharmaceutical sectors."